Patents by Inventor Luca B. Mileo

Luca B. Mileo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240109920
    Abstract: Disclosed are compounds of formula I and II and pharmaceutically acceptable salts thereof. Also disclosed are methods of treating a neurodegenerative disorder, an inflammatory disease, an autoimmune disease, an ophthalmic disease or a metabolic disorder using the compounds disclosed herein.
    Type: Application
    Filed: October 4, 2023
    Publication date: April 4, 2024
    Inventors: Dean R. Artis, Colin P. Leslie, Luca B. Mileo, Claudia Beato, Federico Sorana, Bruno Di Guglielmo, Chiara Padroni
  • Patent number: 11814404
    Abstract: Disclosed are compounds of formula I and II and pharmaceutically acceptable salts thereof. Also disclosed are methods of treating a neurodegenerative disorder, an inflammatory disease, an autoimmune disease, an ophthalmic disease or a metabolic disorder using the compounds disclosed herein.
    Type: Grant
    Filed: July 19, 2021
    Date of Patent: November 14, 2023
    Assignees: ANNEXON, INC., APTUIT (VERONA) SRL
    Inventors: Dean R. Artis, Colin P. Leslie, Luca B. Mileo, Claudia Beato, Federico Sorana, Bruno Di Guglielmo, Chiara Padroni
  • Publication number: 20230265109
    Abstract: Disclosed are compounds of formula I and II and pharmaceutically acceptable salts thereof. Also disclosed are methods of treating a neurodegenerative disorder, an inflammatory disease, an autoimmune disease, an ophthalmic disease or a metabolic disorder using the compounds disclosed herein.
    Type: Application
    Filed: January 17, 2023
    Publication date: August 24, 2023
    Inventors: Dean R. Artis, Colin P. Leslie, Luca B. Mileo, Glaudia Beato, Federico Sorana, Bruno Di Guglielmo, Chiara Padroni, Federica Faroldi
  • Publication number: 20220048930
    Abstract: Disclosed are compounds of formula I and II and pharmaceutically acceptable salts thereof. Also disclosed are methods of treating a neurodegenerative disorder, an inflammatory disease, an autoimmune disease, an ophthalmic disease or a metabolic disorder using the compounds disclosed herein.
    Type: Application
    Filed: July 19, 2021
    Publication date: February 17, 2022
    Inventors: Dean R. Artis, Colin P. Leslie, Luca B. Mileo, Claudia Beato, Frederico Sorana, Bruno Di Guglielmo, Chiara Padroni